Hirofumi Mukai

8PUBLICATIONS
30CO-AUTHORS
Social epidemiologyDeep learningCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 30, 2026
Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial.

Yosuke Aoyama, Kosuke Kashiwabara, Yuichiro Kikawa

|Jul 03, 2025
Development of a deep learning-based automated diagnostic system (DLADS) for classifying mammographic lesions - a first large-scale multi-institutional clinical trial in Japan.

Takeshi Yamaguchi, Yoichi Koyama, Kenichi Inoue

|Apr 20, 2023
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial.

Takuji Iwase, Shigehira Saji, Kotaro Iijima

|Nov 23, 2022
Efficacy of Telemedicine Using Videoconferencing Systems in Outpatient Care for Patients With Cancer: A Systematic Review and Meta-Analysis.

Yasuaki Uemoto, Taro Yamanaka, Yuki Kataoka

|Sep 04, 2021
Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancer.

Hirofumi Mukai, Yukari Uemura, Hiromitsu Akabane

|Apr 09, 2021
Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer.

Naruto Taira, Masataka Sawaki, Yukari Uemura

Pageof 2

Frequent Collaborators

3 joint publications

Naruto Taira

2 joint publications

Masato Takahashi

2 joint publications

Takeshi Yamaguchi

1 joint publications

Masataka Sawaki